"#OBIPharma Granted U.S. #FDA #OrphanDrugDesignation for the Treatment of #GastricCancer for Its #AntibodyDrugConjugate (#ADC) #TargetedCancerTherapy, #OBI999 https://t.co/ic9enWY2Pg"

OBI-999 - OBI Pharma

Jan 22, 2020